ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag drug development fda biobusiness business

Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019 | 9 min read
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
a photo of the packaging for the drug Trikafta
FDA Approves New Cystic Fibrosis Drug
Shawna Williams | Oct 24, 2019 | 1 min read
The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015 | 2 min read
The personal genomics firm announces plans to make medicines.
Roche Buys Biotech for $8.3B
Jef Akst | Aug 27, 2014 | 1 min read
The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.
Braving the IPO Drought
Megan Scudellari | Mar 1, 2012 | 7 min read
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Spraying spray bottle
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Jef Akst | Jun 13, 2022 | 10+ min read
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
Antibody-Drug Combo Approved
Dan Cossins | Feb 25, 2013 | 2 min read
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Cannabis Biotech
Daniel Cossins | Dec 1, 2014 | 8 min read
As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.
A vet and technician take a sample from a dog for use in PetDx’s OncoK9 test, which screens cell-free DNA for genomic alterations associated with cancer.
The Pet Health Industry Takes on Canine Cancer
Diana Kwon | Oct 17, 2022 | 9 min read
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
Accessing Drugs for Medical Aid-in-Dying
Catherine Offord | Aug 16, 2017 | 9 min read
A fraught market for the barbiturates prescribed to terminally ill patients who choose to end their lives has physicians turning to options outside big pharma.

Run a Search

ADVERTISEMENT